Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease: Evaluation of Exposure Parameters

NCT06381518 is registered in ClinicalTrials.gov with Zuyderland Medisch Centrum as lead sponsor.

NCT NCT06381518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06381518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease: Evaluation of Exposure Parameters
Lead sponsor
Zuyderland Medisch Centrum
Phase
Not applicable
Overall status
Completed
Start date
March 12, 2024
Completion date
December 1, 2025
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ibd, infliximab, ulcerative colitis